ABSTRACT. The half-lives for coagulation factors in the the response of the "fetal" fibrinogen to thrombin in vivo. Many healthy newborn infant are not known and may be different of these questions can only be asked ethically in an animal model than for the adult. We measured the half-life for fetal of newborn coagulation. We have used the sheep model to sheep fibrinogen and compared it to the half-life of adult investigate the clearance and response to thrombin of "fetal" and sheep fibrinogen. Fibrinogen was purified from adult and adult fibrinogen. Our results show that fibrinogen, whether adult fetal sheep plasma and radiolabeled with either '251 or 13'I. or fetal, has a faster turnover in the newborn compared to the The half-lives for these fibrinogens were determined in the adult and that both adult and fetal fibrinogen have a similar adult sheep and newborn lamb. In addition, the fetal and response in vivo to thrombin. adult sheep fibrinogens were compared by reptilase time, thrombin clotting time, sialic acid content, and the behavior of the N-glycans derived from these fibrinogens on the MATERIALS AND METHODS immobilized lectin, Sepharose-concanavalin A. Finally, the ~~i~~l model, plasma for purification of fibrinogen was obin vivo response of coinjected radiolabeled fibrinogens to tained from adult sheep and from fetal lambs at approximately increasing doses of infused thrombin was determined. The 100 days gestation with tern being 147 days gestation. T~ obtain fetal sheep fibrinogen differed from the adult as indicated the fetal plasma, the pregnant ewe was given an epidural anesby a prolonged reptilase time and an increased sialic acid thetic supplemented with sedative doses of sodium pentobarbital content residues/340 Kd versus adult: 8-9 by continuous intravenous infusion. The fetal lamb was partially residues1340 Kd). The latter was also reflected in differing delivered in a breech position through a uterine incision. silastic chromotographic profiles for the N-gl~cans on Se~harose-catheters were placed in the fetal lamb's femoral artery and the concanavalin A. The half-lives for both the adult and fetal fetal blood obtained. fibrinogen were significantly more rapid in the newborn Fibrinogen purification. Blood for fibrinogen purification was lamb (fetal: 47 2-0 h; adult: 46 2-4 h, mean SEM) collected into polypropylene tubes containing 3.8% sodium citthan in the adult (fetal: 116 f 6.5 h; adult: 121 f 6.9 h). rate and EACA. A fraction of the blood obtained was centrifuged Finally, the adult and fetal sheep fibrinogen responded to at 3000 x g for 20 min and multiple aliquots of the plasma thrombin in an identical fashion in the intact animal. In sample frozen at -70" c for future coagulation assay. ~h~ summary, both adult and fetal fibrinogen have faster half-remaining plasma was used for fibrinogen purification according lives in the lamb compared to the adult, despite a higher to the method of Straughn and Wagner (7). In brief, the fibrinsialic acid content for the fetal fibrinogen. We speculate ogen was prepared by absorbing plasma with aluminum gel that the more rapid turnover of coagulation proteins in the followed by three precipitation steps with palanine. The final newborn may be of significance when planning replacement precipitate was resuspended in a citrate saline solution and therapy for congenital or acquired coagulopathies. (Pediatr frozen. Purified fetal fibrinogen was labeled with 1251 and adult Res 23: [249][250][251][252]1988) fibrinogen with "'I using the iodine monochloride technique (8).
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Thrombin infusion experiments.
In these experiments both 1251-fetal fibrinogen and '"I-adult fibrinogen were injected into healthy adult sheep ( n = 3) at least 24 h before study. On the day of study, two catheters were placed in the jugular veins. Exogenous bovine thrombin was infused into the right jugular vein at increasing doses (0.1-1.2 U/kg/min). Blood samples were obtained as described above from the left jugular vein over the subsequent 2-h time period. Evidence for a '~eta1"fibrinogen. To confirm the presence of a "fetal" fibrinogen in the fetal lamb, both a 2-U thrombin clotting time, performed with and without calcium, and a reptilase time were performed in both fetal lamb plasma samples and adult sheep plasma samples. Sialic acid analyses of the purified fetal and adult fibrinogens were performed in duplicate using mild acid hydrolysis followed by the periodate oxidation-thiobarbituric acid method of Aminoff (lo) using N-acetyl neuraminic acid (Sigma Chemical Co., St. Louis, MO) as a standard. N-glycans were produced from fibrinogen by hydrazinolysis as described by Fukuda et al.
(1 1) except that the glycans were desalted after cleavage and rotary evaporation on Biogel P-2 instead of Sephadex G-25. Chromatography of the isolated N-glycans on Sepharose-concanavalin A was carried out as previously described (12) . Sialic acid analysis of the separated, concentrated fractions was performed. 
RESULTS
Evidence for a fetalfibrinogen. Because the newborn lamb has a lower fibrinogen concentration than the adult sheep, the adult plasma was diluted in saline to a similar fibrinogen concentration as in the lamb. The fetal plasma showed a significantly prolonged reptilase time compared to the adult sheep plasma and a similar trend for the thrombin clotting time in the absence but not in the presence of Ca++ (Table 1) . Analysis of the sialic acid content showed that fetal fibrinogen samples contained considerably more sialic acid (10.4, 10.5 residues/molecule) than adult fibrinogen (8.8, 8.8 residues/molecule) ( Table 2) . Furthermore, the isolated N-glycan fraction from fetal fibrinogen largely passed through Sepharose-concanavalin A (60%) whereas less than 10% of glycans from adult fibrinogen passed through the lectin column. This confirmed the increased sialic acid content of the fetal fibrinogen and indicated that the majority of glycans on adult fibrinogen was biantennary whereas most fetal glycans were more branched (1 2). Turnover studies. The pharmacokinetic curves for both fetal and adult fibrinogen were markedly different in the newborn lamb compared to the adult sheep ( Figs. 1 and 2 ). The half-lives for both fetal and adult fibrinogen were significantly shorter in the newborn lamb compared to the adult sheep (40% of the adult value) ( Table 3 ). The half-life of '2SI-albumin in the lamb was 67% of the value in the adult sheep (Table 3) .
Response to thrombin infusion. Figure 3 shows the response of the fetal and adult fibrinogen to an infusion of thrombin (the same thrombin used for the thrombin clotting times). At a dose of 1 U/kg/min of thrombin, both the adult and fetal fibrinogen showed an increased consumption that was comparable for both fibrinogens. * Determined from the sialic acid content of the N-glycans samples after chromotography on Sepharose-concanavalin A.
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Fig. 1. The plasma survival curves of radiolabeled fetal lamb fibrinogen in the adult sheep ( . , n = 5) and newborn lamb (0, n = 5). The fetal fibrinogen had a consistently faster turnover in the lamb compared to the sheep. The values are all expressed as the mean with all SEM less than 5%.
DISCUSSION
The hemostatic system in the newborn infant has unique features when compared to the hemostatic system in the adult. One aspect of interest is the evidence for "fetal" forms of coagulation factors (3) (4) (5) (14) (15) (16) and their influence on the turnover of the coagulation protein in physiologic and pathophysiologic states. Because these studies would be generally considered unethical in the healthy human infant, they necessitate the use of an animal model. The fetal sheep was chosen for our study because the -fetal sheep has been described as one model for the newborn coagulation system (17) and the lamb fibrinogen may t Statistical difference between the newborn and adult of p < 0.0 1. exist in a "fetal" form (1 8). Herein we show that sheep fibrinogen, whether fetal or adult, has a more rapid clearance in the healthy newborn lamb compared to the adult sheep. In addition, both the fetal and adult sheep fibrinogen respond in a similar fashion in vivo to a challenge with thrombin even though carbohydrate analyses r~vealed significant differences between the fetal and adult fibnnogen in sialic acid content and in the degree of branching of the N-glycans. Thus, the increased sialic acid content likely contributed to the in vitro demonstration of a dysfibrinogenemia in the lamb but did not contribute to the more rapid clearance of fibrinogen in the lamb.
We chose to study the clearance of fibrinogen because of its importance in blood clotting and because of the evidence for a "fetal" form of fibrinogen in the human infant. An increased sialic acid content is one of the main differences between human newborn and adult fibrinogen and is responsible for the delayed polymerization observed for the human fetal fibrinogen ex vivo (3) (4) (5) . We were able to demonstrate similar abnormalities in fetal sheep fibrinogen compared to the human infant. Conceivably the presence of an increased sialic acid content and an altered N-glycans branching profile in the fetal sheep fibrinogen molecule could result in a different response to thrombin in vivo as well as in vitro. We tested this hypothesis by directly infusing thrombin into the adult sheep containing both I2'I-fetal and I3'Iadult fibrinogens and demonstrated their similar response to thrombin. This observation indicates that the different carbohydrates carried by these fibrinogens are unlikely to influence the role of fibrinogen during intravascular coagulation. This conclusion agrees with the reports of Nishibe and Takahashi (19) and Gilman et al. (20) who found that neither deglycosylation nor the inhibition of glycosylation during biosynthesis changed the coagulant properties of fibrinogen. The physiologic reason for the increased sialic acid content of fetal sheep fibrinogen is not obvious. Other fetal proteins such as human fetal fibronectin (2 1) and human placental fibronectins (22) also contain a higher carbohydrate content than in the adult plasma. For fibronectin, as the carbohydrate content increases, the binding between fibronectin and collagen decreases. Whether the high sialic acid of fetal sheep fibrinogen alters functional properties in vivo is unknown.
Information on pharmacokinetics of coagulation factors in the healthy human full-term or premature infant is sparse and largely confined to the sick infant. Premature human infants with varying degrees of the respiratory distress syndrome show shortened I2'I-fibrinogen survivals (half-life of 2.8 to 2.1 days) compared to healthy adults (4.5 days) (23, 24) . One cannot be sure if these shortened fibrinogen survivals reflect a physiologic phenomena or a disease process. Indeed, antithrombin I11 survivals are reported to be shorter in reasonably healthy infants requiring an exchange transfusion for hyperbilirubinemia compared to the adult (25) . In addition, small animals show a faster turnover of proteins in general compared to large animals, likely due to an increased basal metabolic rate. The shorter half-life for albumin in the newborn lamb compared to the adult sheep is compatible with this observation. The shorter half-life for at least one coagulation factor, fibrinogen, in a healthy newborn animal compared to the adult is likely in large part to be due to an increased metabolic rate. The similar rates of clearance observed for either fibrinogen in the lamb or the adult sheep (Figs. 2 and 3) indicate that, probably, differences in sialic acid content and the branched nature of the N-glycans do not contribute toward the catabolism of fibrinogen. A similar conclusion was made by Barsigian et a/. (26) who calculated similar half-lives for rabbit native fibrinogen and aglycofibrinogen in rabbits. Also, the early work of Wong et al. (27) demonstrated that plasma clearance of transfenin in rabbits was independent of any preceding desialylation in vivo. we also acknowledge the technical skills of Dr. M. Smith and A.
Marianski.
